SEC Filings
AstraZeneca Wins Bladder Cancer Approval After Imfinzi Regimen Cuts Death Risk 42% In Trial
The treatment expands Imfinzi's reach to patients unable or unwilling to take cisplatin, but severe adverse events were more common.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The treatment expands Imfinzi's reach to patients unable or unwilling to take cisplatin, but severe adverse events were more common.
Deals
The completed merger brings 2.2 million utility customers under one parent, with new finance and integration chiefs.
SEC Filings
Subsidiaries borrowed $600 million Friday, and the aircraft-engine service company is seeking more revolving credit.
Deals
Each NorthWestern share converts into a right to 0.98 parent shares, with Bright Horizon scheduled to trade on the NYSE under HZN Monday.
SEC Filings
The rare-disease treatment improved patients’ daily activities versus placebo, with benefits starting in week one.
Earnings
The food and facilities services company raised its quarterly dividend 17% and expects further sales and adjusted earnings growth.
SEC Filings
New common shares account for about 19% of post-offering shares as the company prepares for regulatory discussions.
SEC Filings
The new shares account for about 4% of the post-offering total as the company prepares to spin off its coffee business.
SEC Filings
The Australian manager reported sole voting authority over the position and classified the holding as passive.
SEC Filings
Atlas Diversified Master Fund directly owns the shares, while Tandem plans U.S. and Canadian product additions in 2027.
Earnings
Vehicle margins improved from the second quarter, while XPENG expects fourth-quarter deliveries to grow about 45%–50% from a year earlier.
SEC Filings
The other named executive officers' agreements will run through December 31, 2028, under an existing extension provision.